PortfoliosLab logo

Bone Biologics Corporation (BBLG)

Equity · Currency in USD · Last updated Mar 28, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Bone Biologics Corporation in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $22 for a total return of roughly -99.78%. All prices are adjusted for splits and dividends.

BBLG (Bone Biologics Corporation)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BBLG

Bone Biologics Corporation


Bone Biologics Corporation had a return of 8.57% year-to-date (YTD) and -91.94% in the last 12 months. Over the past 10 years, Bone Biologics Corporation had an annualized return of -95.68%, outperforming the S&P 500 benchmark which had an annualized return of -2.58%.

1 month-24.50%0.19%
6 months-80.17%7.70%
1 year-91.94%-12.45%
5 years (annualized)-97.54%-2.83%
10 years (annualized)-95.68%-2.58%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Bone Biologics Corporation Sharpe ratio is -0.90. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BBLG (Bone Biologics Corporation)
Benchmark (^GSPC)

Dividend History

Bone Biologics Corporation doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BBLG (Bone Biologics Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Bone Biologics Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Bone Biologics Corporation is 99.87%, recorded on Dec 28, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.87%Aug 17, 2017380Dec 28, 2022
-78.45%Aug 18, 201618Jan 3, 201717Jul 18, 201735
-2%Jul 22, 20161Jul 22, 20161Aug 8, 20162

Volatility Chart

Current Bone Biologics Corporation volatility is 59.85%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BBLG (Bone Biologics Corporation)
Benchmark (^GSPC)